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Artificial lungs are in use, but difficult issues remain in the field of membrane development related to 
fouling issues. Currently there are external artificial lungs circulating blood outside the body, taking out 
the carbon dioxide, and inserting oxygenated blood back into the body. An example of this type of 
machine is the ExtraCorporeal Membrane Oxygenation (ECMO) machine currently used in hospitals. The 
ECMO takes over the functions for both the lungs and the heart but is only available for short term use by 
patients with respiratory failure due to infections (1). The fibers in the machine develop fouling due to the 
fibers’ small surface areas coupled with their long term exposure to proteins in the blood. These factors 
continuously decrease the gas transfer abilities of the fibers until the machine is no longer effective at 
exchanging gases with the blood. The goal of this research is to create a lung that can function within the 
body until an actual lung becomes available using hollow fiber membranes with proteins attached to 
prevent fouling.  A fouling study was performed on 17.8% polysulfone hollow fiber membranes with 
polydopamine and peptoid attached. Unmodified, polydopamine modified, and polydopamine and peptoid 
modified fibers were placed in a diffusion chamber with Bovine Serum Albumin (BSA) flowing on the 
outside of the fibers and oxygen flowing on the inside. Evapoporometry was run on the fibers to 
determine the pore size distribution of the fibers before and after the run. The evapoporometry of the 
fibers shows that the pores for the fibers after 48 hours in the chamber are smaller overall with a few 
larger pores from oxygen flowrate being too high, tearing the pores. There were also fewer pores overall 
in the fibers after the run; therefore, the fibers are fouling in the diffusion chamber. The oxygen 
concentration of the BSA was also measured while the BSA was run outside of the fibers in the chamber. 
The fibers were considered to be completely fouled when no more oxygen was able to diffuse into the 
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